Department of Experimental Clinical Oncology

Error in site JavaScript
Untitled Document

PUBLIKATIONER 1994

 

335.      Andersen, J.: Determination of Estrogen receptors in parrafin-embedded tissue. Acta Obstetrica et Gynecologica  73: 1-3, 1994.

336.      Armand, J.P., Alberto, P., Costa, A. Estape, J. Jones, R.V.H. Overgaard, J. & Sherman, C.D.Jr.: European School of Oncology Advisory Report to the Commission of the European Communities for the "Europe Against Cancer Proframme". Continuing Medical Education in Oncology Within the European Union. Eur. J. Cancer 30A: 1145-1148, 1994.

337.      Bentzen, S.M.: Quantitative clinical radiobiology. Dr. med. Thesis, Faculty of Health Science ,University of Aarhus. Eget forlag, 1994.

338.      Bentzen, S.M.: Prediction of radiotherapy response using SF2: Why it may work at all. Radiotherapy and Oncology 31: 85-88, 1994.

339.      Bentzen, S.M.: Radiobiological considerations in the design of clinical trials. Radiotherapy and Oncology 32: 1-11, 1994.

340.      Bentzen, S.M. & Overgaard, J. (Guest editors): Normal tissue effects of radiation therapy. Special issue. Seminars in Radiation Oncology. Vol 4 , No. 1994.

341.      Bentzen, S.M. & Overgaard, J.: Normal tissue effects of radiation therapy - an introduction. Special issue. Introduction. Seminars in Radiation Oncology 4: 53-54, 1994.

342.      Bentzen, S.M. & Overgaard, J.: Patient-to-patient variability in the expression of radiation-induced normal-tissue injury. Seminars in Radiation Oncology 4: 68-80, 1994,

343.      Bentzen, S.M. & Overgaard, M.: Clinical radiobiology and normal-tissue morbidity after breast cancer treatment. In: Altman, K.I. & Lett, J.T. (eds.): Advances in Radiation Biology, vol 18, pp. 25-51, Academic Press, New York, 1994.

344.      Brincker, H. & Bentzen, S.M.: A re-analysis of available dose-response and time-dose data in Hodgkin's disease. Radiotherapy and Oncology 30:227-230, 1994.

345.      Bundgaard, T., Bentzen, S.M., & Wildt, J.: The prognostic effect of tobacco and alcohol consumption in intra-oral squamous cell carcinoma. Eur. J. Cancer 30B: 323-328, 1994.

346.      Chaplin, D.J. & Horsman: The influence of tumour temperature on ischemia-induced cell death: potential implications for the evaluation of vascular mediated therapies. Radiotherapy and Oncology 30: 59-65, 1994.

347.      Chaplin, D.J. & Horsman, M.R.: The effect of artificially induced ischemia on tumour cell survival. Adv. Exp. Med. Biol. 345: 437-443, 1994.

348.      Grau, C.: Radiobiological studies on the importance of tumor oxygation for anti-neoplastic therapy. Dr. med. Thesis, Faculty of Health Science, University of Aarhus. 1994.

349.      Grau, C., Høyer, M. & Overgaard, J.: The in vivo interaction between vincristine and radiation in the C3H mammary carcinoma and the feet of CDF1 mice. Int. Radiat. Oncol. Biol. Phys. 30: 1141-1145, 1994.

350.      Grau, C., Khalil, A.A., Nordsmark. M., Horsman, M.R. & Overgaard, J.: The relationship between carbon monooxide breathing, tumour oxygenation and local tumour control in the C3H mammary carcinoma in vivo. Br. J. Cancer 69: 50-57, 1994.

351.      Grau, C., Nordsmark, M., Khalil, A.A., Horsman, M.R. & Overgaard, J. Effect of carbon monoxide breathing on hypoxia and radiation response in the SCCVII tumor in vivo. Int. J. Radiat. Oncol. Biol. Phys. 29: 449-454, 1994.

352.      Hansen, O.: Experimantal studies of repopulation anfter radiotherapy and chemotherapy. Ph.D. Thesis, Faculty of Health Science, University of Odense. 1994.

353.      Horsman, M.R.: Modifiers of tumor blood supply. In: Hyperthermia and Oncology, Vol 4. (eds.: Urano, M. & Douple, E.) VNU Scientific Publishers, The Netherlands, pp. 259-283, 1994.  

354.      Horsman, M.R. and Chaplin, D.J. Enhancement of cyclophosphamide cytotoxicity in vivo by the benzamide analogue pyrazinamide. Br. J. Cancer 69: 648-454, 1994.

355.      Horsman, M.R., Christensen, K.L. & Overgaard, J.: Importance of nicotinamide dose on blood preasure changes in mice and humans. Int. J. Radiat. Oncol. Biol. Phys. 29: 455-458, 1994.

356.      Horsman, M.R., Khalil, A., Nordsmark, M., Grau, C. and Overgaard, J. Measurement of pO2 in a murine tumour and its correlation with hypoxic fraction. Adv. Exp. Med. Biol. 345: 493-500, 1994.

357.      Horsman, M.R., Nordsmark, M., Khalil, A., Chaplin, D.J. & Overgaard, J.:  Tumour radiosensitization by nicotinamide: Is it the result of an improvement in tumour oxygenation?  Adv. Exp. Med. Biol. 345: 403,409, 1994.

358.      Horsman, M.R., Khalil, A.A., Siemann, D.W., Grau, C., Hill, S., Lynch, E.M., Chaplin, D.J. & Overgaard, J.: Relationship between radiobiological hypoxia in tumors and electrode measurements of tumor oxygenation. Int. J. Radiat. Oncol. Biol. Phys. 29: 439-442, 1994.

359.      Horsman, M.R., Nordsmark, M., Khalil, A., Hill, S.A., Chaplin, D.J., Siemann, D.W. & Overgaard, J.:  Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing. Acta Oncologica 33: 371-376, 1994.

360.      Horsman, M.R., Siemann, D.W., Nordsmark, M., Khalil, A.A., Overgaard, J. & Chaplin, D.J. (1994) The combination of nicotinamide and carbogen breathing to improve tumour oxygenation prior to radiation treatment. In: Hogan, M.C., Mathieu-Costello, O., Poole D.C. & Wagner, P.D. (eds.) Oxygen Transport to Tissue XVI. , Plenum Press, New York, pp. 635-642, 1994.

361.      Høyer, M: A flow cytometric model for description of tumour cell proliferation.  Ph.D. Thesis, Faculty of Health Science, University of Aarhus. 1994.

362.      Høyer, M., Bentzen, S.M. & Overgaard, J.: Influence of sampling time on assessment of potential doubling time. Cytometry 16: 144-151, 1994.

363.      Jensen, A.B., Hansen, O., Jørgensen, K. & Bastholt, L.: Influence of late side-effects upon daily life after radiotherapy for laryngeal and pharyngeal cancer. Acta Oncologica 33: 487-491, 1994.

364.      Johansen, J., Bentzen, S.M., Overgaard, J. & Overgaard, M.: Evidence of a positive correlation between in vitro radiosensitivity of normal human skin fibroblasts and the development of subcutaneous fibrosis after radiotherapy. Int. J. Rad. Biol. 66: 407-412, 1994.

365.      Johansen, J., Taagehøj, F., Christensen, T., Overgaard, J. & Overgaard, M.: Quantitative magnetic resonance for assessment of radiation fibrosis after post-mastectomy radiotherapy. Br. J. Radiology 67: 1238-1242.

366.      Lindstamm. J., Einhorn, J. & Overgaard, J.: Acta Oncologica. A product of Lars-Gunnar Larsson (editorial). Acta Oncologica 33: 339-340, 1994.

367.      Lundbeck, F.: The normal mouse urinary bladder reservoir function evaluated by repeated cystometries. Early and late changes with cis-diamminedichloroplatinum (II) or cyclophosphamide. Scand. J. Urol. Nephrol. Suppl. 166, 1994. Dr. med. Thesis, Faculty of Health Science ,University of Aarhus. 1994.

368.      Nordsmark, M., Bentzen, S,M. & Overgaard, J.: Measurement of human tumour oxygenation stsatus by a polarographic needle electrode. An analysis of inter- and intra tumour heterogeniety. Acta Oncologica 33: 383-389, 1994.

369.      Overgaard, J: Hyperthermie. GBK. Krebsdiagnostik und Therapie, no. 64: 39-42, 1994.

370.      Overgaard, J.: Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors. Oncology Research 6: 507-516, 1994.

371.      Parkins, C.S., Hill, S.A., Lonergan, S.J., Horsman, M.R., Chadwick, J.A. & Chaplin, D.J. Ischaemia induced cell death in tumors: importance of temperature and pH. Int. J. Radiat. Oncol. Biol. Phys. 29: 499-503, 1994.

372.      Pedersen, D.: Continuous and split-course radiotherapy in locally advanced carcinoma of the uterine cervix. Analyses of local control, distant metastases, crude survival, early and late morbidity and prognostic factors. Ph.D. Thesis, Faculty of Health Science, University of Aarhus, 1994.

373.      Pedersen, D., Bentzen, S.M. & Overgaard, J.: Continous or split-course combined external and intracavitary radiotherapy of locally advanced carcinoma of the uterine cervix. Acta Oncologica 33: 547-555, 1994.

374.      Pedersen, D., Bentzen, S.M. & Overgaard, J.: Early and late radiotherpeutic morbidity in 442 consecutive patients with locally advanced carcinoma of the uterine cervix. Int. J. Radiat. Oncol. Biol. Phys. 29: 941-952, 1994.

375.      Raskmark, P., Hornsleth, S., Salling, L.N., Lindegaard, J.C. & Overgaard, J.: Deep heating using a movable applicator phased array hyperthermia system. A preclinical feasibility study. Acta Oncologica 33: 451-455, 1994.

376.      Raskmark, P., Larsen, T. & Hornsleth, S.: Multi-applicator hyperthermia system describtion using scattering parameters. Int. J. Hyperthermia 10: 143-151, 1994.

377.      Safwat, A.A.: Clinical, physiological and radiobiological aspects of total body irradiation. Dr. med. Thesis, Faculty of Health Science, University of Cairo. 1994.

378.      Salling, L.N.: Eksperimentel prostatacancer. Karaktertisering af prostatacarcinomets cellulære parametre, vækst- og miljøparametre i en eksperimentel tumormodel og relevante behandlingers effekt på disse.  Ph.D. Thesis, Faculty of Health Science, University of Aarhus. 1994.

379.      Sand Hansen, H., Overgaard, J., Overgaard, M., Jørgensen, K., Bastholt, L., & Berthelsen, A.: Continuous versus spli-course radiotherapy of advanced supraglottic carcinoma - experience from the Danish Head and Neck Cancer Study. In: Laryngeal cancer. Smee, R. & Bridger, G.P. (eds.), Elsevier Science B.V., Amsterdam, pp 465-470, 1994.

380.      Schumacher, B., Keller, J. & Hvid, I.: Distraction effects on muscle. Leg legthening studied in rabbits. Acta Orthop. Scand. 65: 647-50, 1994.

381.      Siemann, D.W., Horsman, M.R. & Chaplin, D.J.: The radiation response of KHT sarcomas following nicotinamide treatment and carbogen breathing. Radiotherapy and Oncology 31: 117-122, 1994.

382.      Stewart, F.A., Oussoren, Y., van Tinteren, H. & Bentzen, S.M.: Loss of reirradiation tolerance in the kidney with increasing time after single or fractionated partial tolerance doses. International Journal of Radiation Biology 66: 169-179, 1994.

383.      von der Maase, H.: Complications of combined radiotherapy and chemotherapy. Seminars in Radiation Oncology 4: 81-94, 1994.